High dose etoposide does not cause peripheral neuropathy
- 1 April 1987
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 19 (2) , 180-181
- https://doi.org/10.1007/bf00254577
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213American Journal of Clinical Oncology, 1983
- Review of etoposide.1983
- Etoposide—chemistry, preclinical and clinical pharmacologyCancer Treatment Reviews, 1982
- Possible enhancement of vincristine neuropathy by VP-16Cancer, 1982
- A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213Cancer, 1975